Cargando…
Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
BACKGROUND: Available data proving the value of DWI for breast cancer diagnosis is mainly for enhancing masses; DWI may be less sensitive and specific in non-mass enhancement (NME) lesions. The objective of this study was to assess the diagnostic accuracy of DWI using different ROI measurement appro...
Autores principales: | Avendano, Daly, Marino, Maria Adele, Leithner, Doris, Thakur, Sunitha, Bernard-Davila, Blanca, Martinez, Danny F., Helbich, Thomas H., Morris, Elizabeth A., Jochelson, Maxine S., Baltzer, Pascal A. T., Clauser, Paola, Kapetas, Panagiotis, Pinker, Katja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894318/ https://www.ncbi.nlm.nih.gov/pubmed/31801635 http://dx.doi.org/10.1186/s13058-019-1208-y |
Ejemplares similares
-
Diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer
por: Horvat, Joao V., et al.
Publicado: (2019) -
A multiparametric [(18)F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
por: Leithner, Doris, et al.
Publicado: (2019) -
Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging
por: Marino, Maria Adele, et al.
Publicado: (2020) -
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results
por: Leithner, Doris, et al.
Publicado: (2019) -
Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes
por: Leithner, Doris, et al.
Publicado: (2019)